VJHemOnc is committed to improving our service to you

ESH AL 2020 | Should AMTL be defined as a distinct diagnostic entity?

VJHemOnc is committed to improving our service to you

Jonathan Bond

Jonathan Bond, MB BCh BAO, MRCPI, FRCPath, PhD, University College Dublin, Dublin, Ireland, discusses recent proposals to define acute myeloid/T-lymphoblastic leukemia (AMTL) as a distinct diagnostic entity. Prof. Bond reveals that the transcriptional overlap in interface acute leukemias provides support for the proposed classification of AMTL as a separate entity. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter